CORDIS - EU research results
CORDIS

Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy

Publications

Identification of a tumor-specific allo-HLA–restricted γδTCR

Author(s): G. J. J. Kierkels, W. Scheper, A. D. Meringa, I. Johanna, D. X. Beringer, A. Janssen, M. Schiffler, T. Aarts-Riemens, L. Kramer, T. Straetemans, S. Heijhuurs, J. H. W. Leusen, E. San José, K. Fuchs, M. Griffioen, J. H. Falkenburg, L. Bongiovanni, A. de Bruin, D. Vargas-Diaz, M. Altelaar, A. J. R. Heck, L. D. Shultz, F. Ishikawa, M. I. Nishimura, Z. Sebestyén, J. Kuball
Published in: Blood Advances, Issue 3/19, 2019, Page(s) 2870-2882, ISSN 2473-9537
Publisher: American Society of Hematology
DOI: 10.1182/bloodadvances.2019032409

Intellectual Property Rights

BISPECIFIC MOLECULES COMPRISING GAMMA-DELTA TCR AND T-CELL OR NK CELL BINDING DOMAIN

Application/Publication number: WO 2019156566
Date: 2019-02-10

COMPOSITIONS AND METHODS FOR CELL TARGETING THERAPIES

Application/Publication number: WO 2018211115
Date: 2018-05-18

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available